Oxidative stress as a catalyst in prostate cancer progression: unraveling molecular mechanisms and exploring

Yawen Song1, Zheng Hou2, Longting Zhu3

  • 1Department of Urology, Xijing Hospital of Air Force Military Medical University, Xi'an, China.

Discover Oncology
|April 3, 2025
PubMed

Insights

Reactive oxygen species (ROS) drive prostate cancer progression and treatment resistance. Understanding ROS generation and their role in the tumor microenvironment is key to developing new antioxidant therapies for prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer incidence and mortality are rising globally.
  • Androgen deprivation therapy (ADT) efficacy is limited by treatment resistance, especially in metastatic disease.
  • Reactive oxygen species (ROS) induce oxidative stress, impacting cellular functions and promoting cancer progression.

Purpose of the Study:

  • To systematically review ROS generation pathways in prostate cancer.
  • To explore the interaction between ROS and androgen receptor signaling.
  • To investigate the influence of external factors like obesity and aging on ROS production.

Main Methods:

  • Systematic literature review of ROS generation in prostate cancer.
  • Analysis of ROS interaction with androgen receptor signaling pathways.
  • Examination of ROS-mediated mechanisms including tumor microenvironment modulation, unfolded protein response (UPR) activation, and miRNA regulation.

Main Results:

  • Elevated ROS levels promote prostate cancer proliferation, invasion, angiogenesis, and extracellular matrix remodeling.
  • ROS contribute to treatment resistance in prostate cancer.
  • External factors like obesity and aging exacerbate ROS production, fueling cancer progression.

Conclusions:

  • ROS play a multifaceted role in driving prostate cancer progression and malignancy.
  • Targeted antioxidant strategies informed by ROS-mediated mechanisms hold promise for novel prostate cancer therapeutics.
  • Further research into ROS pathways could overcome ADT resistance in prostate cancer.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
19
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
32